Migration of polymorphonuclear leucocytes is influenced by dendritic cells.
Dendritic cells (DCs) are the most potent antigen-presenting cells and populate many tissues where they may participate in inflammatory reactions. The infiltration of polymorphonuclear leucocytes (PMNLs) into tissues is a prominent feature of inflammation. The mechanisms of PMNL recruitment depend on chemotactic factors and adhesion molecules expressed on endothelial cells. The aim of the present study was to determine whether DCs participate in the early recruitment of PMNLs. Dendritic cells derived from peripheral blood monocytes were used for this study. PMNLs incubated with culture supernatant (CS) from untreated or from tumour necrosis factor-alpha (TNF-alpha)-treated (1 hr, 100 U/ml, 37 degrees ) monocyte-derived DCs (moDCs) had increased surface expression of both CD11b and CD18. Moreover, both untreated and TNF-alpha-treated moDCs induced PMNL chemotaxis. By blocking CXCL8, CXCL5, CXCL7 and Pan GRO (CXCL1, CXCL2, CXCL3), we observed that CXCL8/interleukin-8 might be the chemokine that induced the PMNL chemotactic activity in the CS of untreated and TNF-alpha-treated moDC. Furthermore, we investigated the regulation of CXCL8 production in moDCs by adhesion molecule engagement. Our data demonstrated that CD31, CD18, CD29 and CD49d participated in the adhesion of immature moDCs to endothelium. Moreover, engagement of domains 1-3 of CD31, but not of CD29 or CD18, decreased the production of CXCL8 by immature but not mature moDCs (which display lower CD31 levels than immature moDCs). Overall, these results suggest that DCs not only trigger a specific immune response, but also the innate immune response by recruiting PMNLs. Furthermore, our results also suggest that CXCL8 production by immature DCs might be regulated by signalling through CD31 during their migration through the vascular endothelium.
Scimone
M Lucila
ML
Laboratorio de Inmunogenética, Hospital de Clínicas José de San Martín, Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
Lutzky
Viviana P
VP
Zittermann
Sandra I
SI
Maffia
Paulo
P
Jancic
Carolina
C
Buzzola
Fernanda
F
Issekutz
Andrew C
AC
Chuluyan
H Eduardo
HE
D000818:Animals; D001853:Bone Marrow / Q000276:immunology; D039481:CD11b Antigen / Q000378:metabolism; D018821:CD18 Antigens / Q000378:metabolism; D002448:Cell Adhesion / Q000276:immunology; D002478:Cells, Cultured; D019743:Chemokines, CXC; D002634:Chemotaxis, Leukocyte / Q000276:immunology*; D017077:Culture Media, Conditioned; D003713:Dendritic Cells / Q000276:immunology*; D004730:Endothelium, Vascular / Q000276:immunology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000276:immunology; D006801:Humans; D007249:Inflammation / Q000276:immunology*; D036341:Intercellular Signaling Peptides and Proteins; D015847:Interleukin-4 / Q000276:immunology; D016209:Interleukin-8 / Q000096:biosynthesis / Q000276:immunology; D008213:Lymphocyte Activation / Q000276:immunology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009504:Neutrophils / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D039481:CD11b Antigen; D018821:CD18 Antigens; C499707:CXCL3 protein, human; D019743:Chemokines, CXC; D017077:Culture Media, Conditioned; D036341:Intercellular Signaling Peptides and Proteins; D016209:Interleukin-8; D014409:Tumor Necrosis Factor-alpha; D015847:Interleukin-4; D016178:Granulocyte-Macrophage Colony-Stimulating Factor
Eur J Immunol. 2001 Mar;31(3):812-22
11241286
J Immunol. 2000 Sep 1;165(5):2588-95
10946286
Nat Immunol. 2001 Jul;2(7):612-9
11429545
Infect Immun. 2002 Mar;70(3):1097-105
11854188
Prostaglandins Leukot Essent Fatty Acids. 2002 May-Jun;66(5-6):459-66
12144865
J Immunol. 2002 Dec 15;169(12):6673-6
12471096
FEBS Lett. 2003 Apr 10;540(1-3):7-14
12681475
J Leukoc Biol. 2003 May;73(5):639-49
12714579
J Immunol. 2003 May 15;170(10):5165-75
12734364
Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):953-64
12689916
J Clin Invest. 1973 Nov;52(11):2745-56
4355998
Anal Biochem. 1987 Apr;162(1):156-9
2440339
Physiol Rev. 1990 Apr;70(2):427-51
1690903
J Immunol Methods. 1991 Jun 3;139(2):271-9
1710634
Lab Invest. 1992 Nov;67(5):617-27
1434539
J Exp Med. 1992 Dec 1;176(6):1693-702
1460426
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3574-7
8475106
J Clin Invest. 1993 Dec;92(6):2768-77
7902847
Cell. 1994 Jan 28;76(2):301-14
7507411
J Immunol. 1994 Apr 15;152(8):3991-7
8144966
Nature. 1998 Mar 19;392(6673):245-52
9521319
Immunobiology. 1998 Mar;198(5):568-87
9561374
J Immunol Methods. 1998 Sep 1;218(1-2):173-87
9819134
Immunology. 1998 Oct;95(2):283-90
9824488
J Immunol Methods. 1999 Feb 1;223(1):77-92
10037236
Eur J Immunol. 1999 May;29(5):1617-25
10359116
Immunol Today. 1999 Dec;20(12):535-7
10636641
Immunol Today. 2000 Mar;21(3):110-3
10689296
Br J Dermatol. 2000 Mar;142(3):401-12
10735943
J Leukoc Biol. 2001 May;69(5):785-93
11358988